Work

Abstract 2118: ABN501: A CLDN3-targeted monoclonal antibody with proven safety, pharmacokinetics, and synergistic anti-tumor efficacy

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-2118

Authors: Saehyung Lee, Jae Choi, Sunghyun Hong, Ha Yeon Park, Ho Jin Lee, Jaemun Kim, Sangin Lee, Seung Hwa Jung, Myeung Ryun Seo, Hobin Yang, Sungyoul Hong, Jun Young Choi, Na Young Kim, Young Kee Shin

Institutions: Seoul National University, Kyungsung University

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409627255

Cites:

Cited by: 1

Related to: 10